Cargando…
Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?
SIMPLE SUMMARY: Glioblastomas are brain tumors with a poor prognosis, and early tumor progression occurs often. Therefore, patients are closely monitored with regular MRI scans, usually at 2–3 month intervals. However, there is no evidence for this strategy, and it is not known if patients benefit f...
Autores principales: | van Dijken, Bart R. J., Doff, Annerieke R., Enting, Roelien H., van Laar, Peter Jan, Jeltema, Hanne-Rinck, Dierckx, Rudi A. J. O., van der Hoorn, Anouk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605145/ https://www.ncbi.nlm.nih.gov/pubmed/37894340 http://dx.doi.org/10.3390/cancers15204973 |
Ejemplares similares
-
Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma
por: van Dijken, Bart R. J., et al.
Publicado: (2021) -
The Correlation of In Vivo MR Spectroscopy and Ex Vivo 2-Hydroxyglutarate Concentration for the Prediction of Isocitrate Dehydrogenase Mutation Status in Diffuse Glioma
por: van Dijken, Bart R. J., et al.
Publicado: (2023) -
Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques
por: van Dijken, Bart R.J., et al.
Publicado: (2018) -
Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma
por: van Dijken, Bart R. J., et al.
Publicado: (2022) -
Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients
por: de Groot, Jesse D., et al.
Publicado: (2023)